Key result
SAPIEN 3 transcatheter heart valve undergoes five-year evaluation for RVOT dysfunction in the COMPASSION S3 trial.
Answers are grounded in this paper and cite their sources.
Pooled analysis demonstrates outcomes for RVOT dysfunction after SAPIEN 3 treatment, indicating long-term effectiveness.
URL: https://www.clinicaltrials.gov; Unique identifier: NCT02744677.
No takes yet. Share an insight, caveat, or question.
Hainstock et al. (2026) studied this question. The SAPIEN 3 transcatheter heart valve was evaluated for five-year outcomes in patients with right ventricular outflow tract dysfunction in the COMPASSION S3 trial.
Synapse has enriched 10 related papers. Consider them for comparative context: